VEGFA and age-related macular degeneration: Elevated levels of VEGF‐A, both at the transcript and protein level, are observed in AMD patients with neovascularization (Frank, 1997; Kvanta et al., 1996), and anti‐VEGF is the standard of care for treating the wet form of AMD (Cabral et al., 2017; Kovach et al., 2012).